Brief: New Ray Medicine International Sees Loss For FY 2019
31/01/2020 13:15
Jan 31 (Reuters) - New Ray Medicine International Holding
Ltd 6108.HK :
* GROUP WILL RECORD A LOSS FOR FY 2019
* EXPECTED RESULT DUE TO SALES DECLINE OF PRODUCT DUE TO
SUSPENSION OF PRODUCTION & SALES OF PRODUCT DURING FY
Source text for Eikon: ID:nHKS2hmVmt
Further company coverage: 6108.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on New Ray Medicine International Holding
See all newsBrief: New Ray Medicine International Holding Says Chu Xueping Resigns As Executive Director
Brief: New Ray Medicine International Posts FY Net Loss Attributable HK$20.1 Million
Brief: New Ray Medicine International To Place Up To 33.4 Million Shares
Brief: New Ray Medicine International Says China New Rich Enters Cooperation Agreement
Brief: New Ray Medicine International Says Unit Disposes 801,000 Jiangxi Rimag Shares For HK$12.8 Million